Risperidone in children with autism and serious behavioral problems.
about
Autism spectrum disordersUse of Atypical Antipsychotics in the Treatment of Autistic DisorderAntipsychotics in the treatment of autismEvidence-based comprehensive treatments for early autismSelective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)Risperidone for autism spectrum disorderEfficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic childrenContemporary assessment and pharmacotherapy of Tourette syndromeToward an exportable parent training program for disruptive behaviors in autism spectrum disorderAdvances in the treatment of fragile X syndromePharmacotherapy of aggression in children and adolescents: efficacy and effect sizeAggression in autism spectrum disorder: presentation and treatment optionsExploring the Validity of Valproic Acid Animal Model of AutismPharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis.Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatmentsCognitive-behavioral therapy for anxiety in children with high-functioning autism: a meta-analysisAutism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applicationsMedical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medicationsThe developmental psychopathology of irritabilityTherapeutic approaches for shankopathiesDeveloping Medications Targeting Glutamatergic Dysfunction in Autism: Progress to DateOxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study.The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot studyGenetics of Common Antipsychotic-Induced Adverse EffectsTemplate to Perpetrate: An Update on Violence in Autism Spectrum DisorderAutism spectrum disorders: early detection, intervention, education, and psychopharmacological managementThe status of pharmacotherapy for autism spectrum disordersLack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autismPharmacotherapy to control behavioral symptoms in children with autismPsychotropic medication use among Medicaid-enrolled children with autism spectrum disordersThe dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interactMice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autismThe serotonin system in autism spectrum disorder: From biomarker to animal modelsTranslational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J miceHaploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disordersEffects of risperidone on dopamine receptor subtypes in developing rat brainAn Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options.
P2860
Q22241097-E44C2DCC-2638-4305-B2C0-3AB4535B2DE4Q22241555-02B489EC-2BFF-4DF9-974F-F41389A98798Q22241891-6AE5343E-898D-4F77-8492-F7DA74EA8D6AQ22242991-6B18B1C8-744E-4799-9637-437C3912DDA8Q24200368-C181BE4F-25A8-4C7C-A92D-DD9C8C4EFE62Q24236316-37E9CF33-6F33-4B0A-92DC-06F8DFE38E77Q24246471-5B064CA7-5C01-497E-8BF8-55A9887146EAQ24564288-D4E1CCA6-AFD8-4EC5-B736-4E17E349C4BFQ24607941-824EE052-5DF2-448A-B2A8-9A30168A5983Q24613892-8D81709A-DA77-486E-81D5-6717849AB5DAQ24632814-D18DD91F-8B6A-4F5E-82AB-ADEF334457B0Q24648097-8C31088C-EFD9-46D8-95B5-D224F820B984Q26744346-D2729435-FD39-4C88-98E3-71D6431539E6Q26771764-5CDA7045-8CB5-4B6A-8AC9-B295AE1FB5ACQ26776479-E2452B78-5E5C-414B-9211-710DAB813A61Q26850307-35C018B2-E8C6-447E-B73E-C0B10E056201Q26862584-24EC6EAC-24A3-4FC3-AD6B-F434B9941A72Q27004613-436BDA09-775F-4F42-815C-C7F61C6BF44AQ27014201-8280DAC6-944D-4AB3-BA13-A5D6F3AFD28EQ27022491-781E7A85-7C6B-4AE4-B5A7-6F9330880C4AQ27024976-D6311325-2C8E-44C5-B6E4-69491462D458Q27025683-4493738B-66FC-492F-AF86-BFF9A8066CD8Q27303760-A2F073D4-3334-4A2F-993A-9F2AD98E474BQ27496706-DE8F84EE-8C63-43D8-94AE-98293227A8E6Q28072893-02CB951C-3469-452A-83FE-766110F4630CQ28079993-98D74E33-9283-4C3B-968F-2886CE5713A7Q28212094-558A1E6D-4344-48B5-AB1D-E81F18C8368DQ28239931-2F273838-530F-49A4-8D37-C577EF83A3E8Q28247116-B79BC731-6965-499D-956A-DC4169E061CDQ28265801-F8E3BCB0-E8A6-4638-8B46-4DB23A55675FQ28270824-27E90138-AB3B-4050-A122-E0D5CDC3A8ACQ28388719-9EBCF419-4509-46BC-AF46-C4B467D639BEQ28390641-EF61475A-AB00-4DF6-8BD1-532B1F71A03DQ28391614-83B5C649-99F1-4192-B0A6-F0AA4B737B39Q28394524-DEE48FE5-AC62-4762-B215-BF12CD4D640CQ28397643-A5890C5A-2169-43FF-A6D7-5D707CC0654DQ28508076-3B145D39-D496-4627-B4A0-24EAB42363ABQ28542649-63AB8847-91B8-42CB-BA83-06B7846EC462Q28574726-945013C5-B47E-4452-A9B3-83BC65A64597Q30235878-F255F1EC-4095-46E8-9FA0-F980FCF349B0
P2860
Risperidone in children with autism and serious behavioral problems.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Risperidone in children with autism and serious behavioral problems.
@ast
Risperidone in children with autism and serious behavioral problems.
@en
type
label
Risperidone in children with autism and serious behavioral problems.
@ast
Risperidone in children with autism and serious behavioral problems.
@en
prefLabel
Risperidone in children with autism and serious behavioral problems.
@ast
Risperidone in children with autism and serious behavioral problems.
@en
P2093
P50
P356
P1476
Risperidone in children with autism and serious behavioral problems.
@en
P2093
Allison Lancor
Andres Martin
Arlene Kohn
Benedetto Vitiello
Bhavik Shah
Daniel Hong
David Posey
Deirdre Carroll
Don McMahon
Elaine Tierney
P304
P356
10.1056/NEJMOA013171
P407
P577
2002-08-01T00:00:00Z